Baxter International (BAX) Competitors $29.50 +0.60 (+2.08%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BAX vs. EW, IDXX, RMD, DXCM, STE, PODD, HOLX, GMED, MASI, and TFXShould you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Globus Medical (GMED), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Baxter International vs. Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Insulet Hologic Globus Medical Masimo Teleflex Edwards Lifesciences (NYSE:EW) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Which has more risk & volatility, EW or BAX? Edwards Lifesciences has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Do institutionals & insiders have more ownership in EW or BAX? 79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 1.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has better valuation & earnings, EW or BAX? Baxter International has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdwards Lifesciences$6.31B6.99$1.40B$6.9310.80Baxter International$15.06B1.00$2.66B$0.20147.50 Is EW or BAX more profitable? Edwards Lifesciences has a net margin of 70.82% compared to Baxter International's net margin of 0.77%. Edwards Lifesciences' return on equity of 20.76% beat Baxter International's return on equity.Company Net Margins Return on Equity Return on Assets Edwards Lifesciences70.82% 20.76% 15.27% Baxter International 0.77%18.30%5.43% Does the MarketBeat Community favor EW or BAX? Edwards Lifesciences received 601 more outperform votes than Baxter International when rated by MarketBeat users. Likewise, 71.03% of users gave Edwards Lifesciences an outperform vote while only 65.62% of users gave Baxter International an outperform vote. CompanyUnderperformOutperformEdwards LifesciencesOutperform Votes133471.03% Underperform Votes54428.97% Baxter InternationalOutperform Votes73365.62% Underperform Votes38434.38% Do analysts rate EW or BAX? Edwards Lifesciences presently has a consensus target price of $79.40, suggesting a potential upside of 6.14%. Baxter International has a consensus target price of $40.45, suggesting a potential upside of 37.13%. Given Baxter International's higher probable upside, analysts plainly believe Baxter International is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edwards Lifesciences 0 Sell rating(s) 15 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.42Baxter International 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18 Does the media refer more to EW or BAX? In the previous week, Edwards Lifesciences had 16 more articles in the media than Baxter International. MarketBeat recorded 24 mentions for Edwards Lifesciences and 8 mentions for Baxter International. Edwards Lifesciences' average media sentiment score of 0.69 beat Baxter International's score of 0.25 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 8 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Baxter International 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryEdwards Lifesciences beats Baxter International on 13 of the 18 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Baxter International News Delivered to You Automatically Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BAX vs. The Competition Export to ExcelMetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$15.06B$4.34B$5.14B$19.19BDividend Yield2.29%44.57%5.09%3.62%P/E Ratio147.5125.3790.0541.30Price / Sales1.0045.921,117.1417.58Price / Cash5.9143.4443.0421.28Price / Book1.777.094.785.32Net Income$2.66B$13.64M$120.31M$989.88M7 Day Performance-2.70%-2.93%-1.92%-3.54%1 Month Performance-10.93%0.28%11.51%-3.68%1 Year Performance-24.13%40.76%30.61%12.14% Baxter International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BAXBaxter International4.5364 of 5 stars$29.50+2.1%$40.45+37.1%-23.6%$15.06B$15.06B147.5160,000Options VolumeNews CoverageHigh Trading VolumeEWEdwards Lifesciences3.9448 of 5 stars$73.84+0.7%$79.40+7.5%+0.9%$43.55B$6.00B10.7419,800IDXXIDEXX Laboratories4.9808 of 5 stars$433.37+0.3%$539.63+24.5%-23.6%$35.49B$3.84B41.6711,000Positive NewsRMDResMed4.5342 of 5 stars$241.36+1.2%$227.91-5.6%+36.4%$35.43B$4.81B31.599,980Positive NewsDXCMDexCom4.9164 of 5 stars$76.38-1.0%$98.00+28.3%-31.4%$29.83B$3.95B46.229,600STESTERIS4.932 of 5 stars$213.74-0.2%$262.50+22.8%-3.5%$21.10B$5.14B48.9118,179Positive NewsPODDInsulet4.2541 of 5 stars$266.78-1.0%$267.44+0.2%+28.2%$18.71B$1.70B46.123,000Positive NewsHOLXHologic4.7224 of 5 stars$73.25-0.5%$89.50+22.2%+1.9%$16.62B$4.03B22.147,063Analyst ForecastGMEDGlobus Medical4.8825 of 5 stars$82.33-0.1%$92.18+12.0%+59.4%$11.21B$2.48B122.675,000Analyst ForecastAnalyst RevisionMASIMasimo3.5649 of 5 stars$177.11+0.6%$170.67-3.6%+49.0%$9.48B$2.04B121.485,200Analyst ForecastTFXTeleflex4.8965 of 5 stars$178.96-0.7%$259.00+44.7%-28.0%$8.31B$2.97B35.8114,500Analyst Forecast Related Companies and Tools Related Companies EW Competitors IDXX Competitors RMD Competitors DXCM Competitors STE Competitors PODD Competitors HOLX Competitors GMED Competitors MASI Competitors TFX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BAX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BAX Stock Alerts